November 4, 2013 Omnicare

Omnicare: We Have the Facts, Now What Does it all Mean?

Berger Montague, one of the nation’s preeminent whistleblower law firms, recently announced its $120 million victory against pharmacy services company Omnicare, Inc. The settlement enters the record books as the highest-ever False Claims Act settlement wherein the U.S. government did not intervene. We reported last week about Omnicare’s extensive experience defending whistleblower lawsuits and its involvement in scams ranging from “swapping” to misrepresentations of fees to U.S. health care agencies like Medicare and Medicaid. We also reviewed the sweeping litigation facing Omnicare in 29 jurisdictions raising allegations of violations of 28 states’ and the District of Columbia’s False Claims Acts.

No one can argue that holding Omnicare accountable for its actions is not in everyone’s best interest. A successful lawsuit not only recovers billions in taxpayer dollars, but may help deter other pharmacy services companies from engaging in similar conduct. But what does this success mean for the future of agencies like Medicare, Medicaid and Tricare, who service tens of millions of Americans and process billions of reimbursement invoices each year? Can this litigation help to put a stop to this conduct? Or is it more likely companies like Omnicare will “roll the dice,” continue their fraud-based profit marginalization and pay the penalties as they come?

History of FCA Reveals Decades of Success

The FCA is one of the most successful pieces of legislation in American history. It has enjoyed an existence spanning three centuries and was highly encouraged by President Lincoln. To date, the FCA is responsible for recovering billions of dollars that would otherwise have escaped the taxpayers’ hands due to overreaching, conniving contractors and medical facilities. In fact, the FCA’s whistleblower provision, which awards a percentage of any settlement or judgment to the person who came forward to report misconduct, is mimicked by several other statutes relating to securities, commodities and tax fraud.

For those who are unsure how our Omnicare work will affect the big picture, imagine if every medical facility considering involvement with dishonest billing practices considered the impact of a successful FCA claim and opted to take an honest, lesser-paid route? Omnicare recently settled its claims for $120 million. That leaves 28 other jurisdictions anxiously waiting their turn at the podium, eager to hold this corrupt organization liable to its taxpayers. Twenty-eight jurisdictions times $120 million, or $3.36 billion, is a settlement worth waiting for.

Never Fear Reporting Misconduct or Fraud

The reason our firm is able to work against companies like Omnicare, PharMerica Corporation, and ChemRx Corporation is because of whistleblowers like pharmacist Donald Gale and facility administrator Marc Silver. We rely on the honesty and integrity of those in the healthcare industry who eventually stand back and say “this isn’t right.” Our verdicts and settlements might never occur but for the courage of these individuals who we can all thank for holding taxpayer exploitation to the light and demanding answers for the fraud that ultimately costs our nation not only billions of dollars, but its faith in the healthcare system.

Contact Us to Learn More

Do you need a Whistleblower Lawyer or want to know more information about Qui Tam Law and your rights under the False Claims Act?

There are three easy ways to contact our firm for a free, confidential evaluation with one of our whistleblower attorneys:

Fill out the contact form on this page.
Email [email protected]
Call (888) 647-9292

Your submission will be reviewed by a Berger Montague qui tam attorney and remain confidential.

schedule a free consultation

"*" indicates required fields

First Name*

Last Name*

Email Address*

Phone Number*

Practice Area

City*

State*

Please describe your potential case or matter.**

By clicking SUBMIT you agree to our Terms of Use and Privacy Policy and you are providing express consent to receive communications from Berger Montague via calls, emails, and/or text messages.